eBook Library Of Health And Living: The Encyclopedia Of Diabetes, 2nd Edition

  • Published By:
  • ISBN-10: 1438136226
  • ISBN-13: 9781438136226
  • DDC: 616.4
  • Grade Level Range: 9th Grade - College Senior
  • 432 Pages | eBook
  • Original Copyright 2011 | Published/Released March 2012
  • This publication's content originally published in print form: 2011
  • Price:  Sign in for price

About

Overview

Second Edition is a complete guide to the different types of this disease, signs and symptoms, and management and treatment. The 246 entries explain the causes of diabetes, how the disease affects the body, and how it impacts daily life. Appendixes include directories of organizations, periodicals, research centers, and Web sites. Key topics include: Carbohydrate and carbohydrate counting, Complications of diabetes, Diabetic eye diseases, Diabetic nephropathy, Diabetic neuropathy, Emergency issues, Gestational diabetes, Insulin and insulin pumps, Lifestyle adaptations, Medications.

Table of Contents

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Contents.
Foreword.
Acknowledgments.
A History of Diabetes From Ancient Times to the Twenty-First Century.
1: Abuse/Neglect.
2: Acanthosis Nigricans.
3: Acarbose (Precose).
4: Ace Inhibitors/Ace Drugs.
5: Acquired Immune Deficiency Syndrome (AIDS).
6: Acromegaly.
7: Adolescents with Diabetes.
8: Adult-Onset Diabetes.
9: African Americans with Diabetes.
10: Age/Aging and Diabetes.
11: Albuminuria.
12: Alcohol.
13: Alcohol Abuse/Alcoholism.
14: Alternative Medicine/Complementary Medicine.
15: Alzheimer’s Disease.
16: American Indians/Alaska Natives.
17: Americans with Disabilities Act (ADA).
18: Amputation.
19: Angiotensin Receptor Blockers (ARBs).
20: Animals and Diabetes.
21: Antibodies to Insulin.
22: Appropriate Blood Pressure Control in Diabetes Trial (ABCD Trial).
23: Asians/Pacific Islander Americans (APIA).
24: Aspirin Therapy.
25: Assisted Living Facilities (ALF).
26: Atherosclerosis/Arteriosclerosis.
27: Autonomic Neuropathy.
28: Bariatric Surgery.
29: Behavioral Modification.
30: Beta Cell.
31: Biguanides.
32: Birth Control.
33: Blindness.
34: Blood Glucose Meters.
35: Blood Glucose Monitoring.
36: Blood Sugar.
37: Blurred Vision.
38: Body Mass Index(BMI).
39: Breast-Feeding.
40: Brittle Diabetes.
41: Calcium Channel Blockers (CCBs).
42: Camps for Children and Adolescents with Diabetes.
43: Canada and Diabetes.
44: Cancer.
45: Carbohydrates and Meal Planning.
46: Cardiovascular Disease (CVD).
47: CARE Trial (Cholesterol and Recurrent Events Trial).
48: Cataract.
49: Charcot’s Arthropathy/Charcot’s Joint.
50: Children of Diabetic Mothers.
51: Children with Diabetes, School-Age.
52: Cholesterol (Good Cholesterol/Bad Cholesterol).
53: Chromium Supplements.
54: Clinical Studies/Research.
55: Coma.
56: Complications of Diabetes and Associated Disorders.
57: Coronary Heart Disease (CHD).
58: Counterregulatory Hormones.
59: C-Peptide.
60: Creatinine.
61: Critically Ill Nondiabetic Patients who Become Hyperglycemic.
62: Cushing’s Syndrome/Cushing’s Disease.
63: Cystitis.
64: Dawn Phenomenon.
65: Death.
66: Dehydration.
67: Dementia.
68: Denial (of Diabetes).
69: Depression and Diabetes.
70: Diabetes Control and Complications Trial (DCCT).
71: Diabetes Insipidus.
72: Diabetes Mellitus.
73: Diabetes Prevention Trials.
74: Diabetic Eye Diseases.
75: Diabetic Ketoacidosis (DKA).
76: Diabetic Nephropathy.
77: Diabetic Neuropathy.
78: Diabetic Retinopathy.
79: Diastolic Blood Pressure.
80: Diet.
81: Dietitian.
82: DIGAMI Study.
83: Digestive Disorders.
84: Disability/Disability Benefits.
85: Diuretics.
86: Driving Issues.
87: Dry Skin (xerosis).
88: Dyslipidemia.
89: Early Detection.
90: Eating Disorders.
91: Education about Diabetes.
92: Elderly.
93: Electrolytes.
94: Emergency Issues in Diabetes.
95: Emergency Medical Identification.
96: Employment.
97: Endocrinologist.
98: End-Stage Renal Disease (ESRD).
99: Erb’s Palsy.
100: Erectile Dysfunction (ED).
101: Euglycemia/Normoglycemia.
102: Exercise.
103: Family, the Impact of Diabetes on.
104: Family and Medical Leave Act (FMLA).
105: Fertility.
106: Fiber.
107: Foot Care.
108: Gangrene.
109: Gastroesophageal Reflux Disease (GERD).
110: Gastroparesis Diabeticorum.
111: Genetic Manipulation/Gene Therapy.
112: Genetic Risks.
113: Gestational Diabetes Mellitus (GDM).
114: Gingivitis.
115: Glaucoma.
116: Glucagon.
117: Glucose.
118: Glucose Intolerance.
119: Glycemic Control.
120: Glycogen.
121: Glycosuria/Glucosuria.
122: Government, Federal.
123: Government, State.
124: Growth Hormone.
125: HDL.
126: Hepatitis C Virus (HCV).
127: Hispanics/Latinos.
128: Home Blood Glucose Monitoring/Self-Blood Glucose Monitoring.
129: Home Health Care.
130: Honeymoon Phase.
131: HOPE Study.
132: Hormone Replacement Therapy (HRT)/Estrogen Replacement Therapy (ERT).
133: Hospitalization.
134: Humalog.
135: Hyperglycemia.
136: Hyperinsulinism/Hyperinsulinemia.
137: Hyperlipidemia.
138: Hyperosmolar Coma.
139: Hypertension.
140: Hypoglycemia.
141: Hypoglycemic Unawareness.
142: Immunizations (Flu/Influenza, Pneumococcal Vaccine, and Others).
143: Impaired Glucose Tolerance (IGT).
144: Infants and Preschool Children with Diabetes.
145: Infections.
146: Injection Devices.
147: Injection/Injection Site Rotation.
148: Insulin.
149: Insulin-Dependent Diabetes Mellitus (IDDM).
150: Insulin Pump.
151: Insulin Resistance.
152: Insurance.
153: Islet Neogenesis Associated Protein (INGAP).
154: Islets of Langerhans.
155: Ketones.
156: Kumamoto Study.
157: Lancet.
158: Lawsuits.
159: LDL.
160: Leprechaunism.
161: Leptin.
162: Lifestyle Adaptations.
163: Macrovascular/Microvascular Disease.
164: Macular Edema.
165: Maturity Onset Diabetes of the Young (MODY).
166: Meals, Timing of.
167: Medicaid.
168: Medicare.
169: Medicare Therapeutic Shoe Act.
170: Medication Adherence/Compliance.
171: Medication Interactions.
172: Medications for Treatment of Type 2 Diabetes.
173: Meglitinides.
174: Menopause.
175: Menstruation.
176: Men with Diabetes.
177: Metabolic Syndrome.
178: Metabolism.
179: Metformin.
180: Microalbuminuria.
181: Myocardial Infarction.
182: Nephrologist.
183: Nephrotic Syndrome.
184: Neurontin (gabapentin).
185: Nocturnal Hypoglycemia.
186: Non-Insulin-Dependent Diabetes Mellitus (NIDDM).
187: Noninvasive Monitor/Testing.
188: Nutrition.
189: Obesity.
190: Onset of Diabetes.
191: Ophthalmologist.
192: Oral Glucose Tolerance Test (OGTT).